National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -3 of 3         results per page
View Search Criteria | Help With Results
           
Last Modified: 1/14/2009     First Published: 9/1/2001  

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


Any age


NCI


MDA-ID-00156
NCI-3410, 3410, NCT00024167

Last Modified: 1/14/2009     First Published: 8/13/2006  

2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Supportive care


Active


18 and over


NCI


RTOG-0517
RTOG 0517, NCT00365105

Last Modified: 4/17/2008     First Published: 11/2/2007  

3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


18 and over


Other, Pharmaceutical / Industry


CRUK-TRAPEZE-2100
PR2100, EUDRACT-2004-002295-41, EU-20782, ISRCTN12808747, SANOFI-AVENTIS-CRUK-TRAPEZE-2100, NOVARTIS-CRUK-TRAPEZE-2100, NCT00554918

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov